Hanne-Leena Hyyrylainen
Overview
Explore the profile of Hanne-Leena Hyyrylainen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luukinen B, Antikainen J, Aittoniemi J, Miikkulainen-Lahti T, Hyyrylainen H, Patari-Sampo A
J Clin Microbiol
. 2024 Feb;
62(3):e0105423.
PMID: 38350859
Importance: This study is the first clinical evaluation report of the novel FluoroType Mycobacteria assay. The assay has the potential to replace the established GenoType NTM product family in identification...
2.
Virolainen M, Grondahl-Yli-Hannuksela K, Rantakokko-Jalava K, Seiskari T, Lonnqvist E, Kolari T, et al.
Eur J Clin Microbiol Infect Dis
. 2023 Nov;
43(2):233-241.
PMID: 38010594
Purpose: Streptococcus pyogenes (mostly termed group A Streptococcus - GAS) is the most important bacterial causative of pharyngitis. However, epidemiology of GAS pharyngitis is not widely established. This study describes...
3.
Kailankangas V, Vilhonen J, Grondahl-Yli-Hannuksela K, Rantakokko-Jalava K, Seiskari T, Auranen K, et al.
Infect Dis (Lond)
. 2023 Apr;
55(6):405-414.
PMID: 37029930
Purpose: (Group A , GAS) is an important human pathogen that can cause severe invasive (iGAS) infections. Throat carriage has been assumed to possibly lead to hematogenous seeding. Retrospective studies...
4.
Froberg G, Maurer F, Chryssanthou E, Fernstrom L, Benmansour H, Boarbi S, et al.
Clin Microbiol Infect
. 2023 Feb;
29(6):758-764.
PMID: 36813087
Objective: For non-tuberculous mycobacteria (NTM), minimum inhibitory concentration (MIC) distributions of wild-type isolates have not been systematically evaluated despite their importance for establishing antimicrobial susceptibility testing (AST) breakpoints. Methods: We...
5.
Mentula S, Paakkanen J, Hyyrylainen H
Diagn Microbiol Infect Dis
. 2022 Jul;
104(2):115757.
PMID: 35870367
We analyzed mycobacterial stain, culture and identification EQA data from altogether 134 laboratories in 15 mainly European countries over a 4-year period. The aim was to get an overview of...
6.
Mentula S, Karkamo V, Skrzypczak T, Seppanen J, Hyyrylainen H, Haanpera M, et al.
Access Microbiol
. 2020 Dec;
2(11):acmi000168.
PMID: 33294771
Rescue dog activity is a heavily increasing form of dog charity. Imported homeless dogs represent a reservoir of zoonotic diseases putting owners, veterinarians and pathologists repeatedly at risk. The clinical...
7.
Musser J, Beres S, Zhu L, Olsen R, Vuopio J, Hyyrylainen H, et al.
J Clin Microbiol
. 2020 Jan;
58(4).
PMID: 31996443
Recently, two related strains with reduced susceptibility to ampicillin, amoxicillin, and cefotaxime, antibiotics commonly used to treat infections, were reported. The two strains had the same nonsynonymous (amino acid-substituting) mutation...
8.
Latronico F, Nasser W, Puhakainen K, Ollgren J, Hyyrylainen H, Beres S, et al.
J Infect Dis
. 2016 Oct;
214(12):1987-1995.
PMID: 27707808
Background: Many countries worldwide have reported increasing numbers of emm89 group A Streptococcus (GAS) infections during last decade. Pathogen genetic factors linked to this increase need assessment. Methods: We investigated...
9.
Hyyrylainen H, Marciniak B, Dahncke K, Pietiainen M, Courtin P, Vitikainen M, et al.
Mol Microbiol
. 2010 May;
77(1):108-27.
PMID: 20487272
Summary The PrsA protein is a membrane-anchored peptidyl-prolyl cis-trans isomerase in Bacillus subtilis and most other Gram-positive bacteria. It catalyses the post-translocational folding of exported proteins and is essential for...
10.
Pietiainen M, Francois P, Hyyrylainen H, Tangomo M, Sass V, Sahl H, et al.
BMC Genomics
. 2009 Sep;
10:429.
PMID: 19751498
Background: Understanding how pathogens respond to antimicrobial peptides, and how this compares to currently available antibiotics, is crucial for optimizing antimicrobial therapy. Staphylococcus aureus has several known resistance mechanisms against...